2014
DOI: 10.2146/ajhp130247
|View full text |Cite
|
Sign up to set email alerts
|

Development of an electronic patient prioritization tool for clinical pharmacist interventions

Abstract: By facilitating the identification and monitoring of patients at high risk for MEs and ADEs, the ART has enabled one hospital's clinical pharmacists to conduct interventions such as medication reconciliation and clinical review in a more timely and targeted manner.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
126
0
2

Year Published

2015
2015
2023
2023

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 56 publications
(129 citation statements)
references
References 18 publications
1
126
0
2
Order By: Relevance
“…Therefore, we believe these indicators may not provide added value to the PAST. Patient factors identified in other research that may improve the ability of PAST to identify high-risk patients without the need for an automated electronic prescribing and administrative system include patient age, number of prescribed medications and difficulty communicating with provider (eg, patient and provider speak different languages) 5 9 10…”
Section: Discussionmentioning
confidence: 99%
“…Therefore, we believe these indicators may not provide added value to the PAST. Patient factors identified in other research that may improve the ability of PAST to identify high-risk patients without the need for an automated electronic prescribing and administrative system include patient age, number of prescribed medications and difficulty communicating with provider (eg, patient and provider speak different languages) 5 9 10…”
Section: Discussionmentioning
confidence: 99%
“…In 2011, the Middlemore Hospital pharmacy department (Auckland, NZ), developed the assessment of risk tool (ART)—software to prioritise inpatients for ADE prevention strategies such as MR and pharmacist review 23. ART flags were derived by literature review to identify important risk factors for ADEs, followed by meetings between Middlemore Hospital’s senior clinical pharmacists and the Quality Improvement Unit (which comprised pharmacists, nurses and doctors) until consensus was reached on the final 38 flags and scores (see online supplementary appendix 1).…”
Section: Introductionmentioning
confidence: 99%
“…Tools to help predict patient requirements for pharmaceutical care in hospitals are however poorly developed. A small number of pharmaceutical assessment screening tools (PASTs) have been designed and introduced to prevent adverse drug events in response to inadequate pharmacy services causing critical medication safety incidents3 to provide clinical pharmacy review in a more timely and targeted manner4 5 and identify complex patients in need of referral to a more experienced clinical pharmacist 6…”
Section: Introductionmentioning
confidence: 99%